HSV-2 vaccine (Redbiotec)

N/A

Report date: 2025/12/12 11:06:22

Base Information

Drug NameHSV-2 vaccine (Redbiotec)
Drug Alias NameVLP vaccine (Redbiotec)RBT-26RBT-3
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRedbiotec AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRedbiotec AG
Active IndicationsN/A
Inactive IndicationsHerpesviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A